EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Hepatocyte Growth Factor Confers Trabecular Meshwork Stem Cell Resilience and Paracrine Protection of Trabecular Meshwork Cells in Glaucoma

Rong Du, Enzhi Yang, Ramesh Ayyala, Yiqin Du

Investigative Ophthalmology & Visual Science · 2026-04-01 · 67 (4) · 1

DOI: 10.1167/iovs.67.4.1 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2026-04-01. Written by Rong Du and 3 co-authors. Institution: Department of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States. Major MEDLINE topics: Trabecular Meshwork, Hepatocyte Growth Factor, Stem Cells, Glaucoma. Cited 4 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

We have reported that trabecular meshwork stem cells (TMSCs) are effective for trabecular meshwork (TM) regeneration. This study aims to investigate different responses of TMSCs and TM cells to TGF-β2 and protective factors in TMSCs.

Methods

Human TMSCs and TM cells were exposed to TGF-β2 with or without antioxidant N-acetylcysteine, TMSC-derived secretome (TMSC-Scr), hepatocyte growth factor (HGF), or HGF receptor inhibitor (HGFI). Cell viability was assessed by the MTT assay. Intracellular reactive oxygen species (ROS) and lipid peroxidation were measured using CellROX and C11-BODIPY, respectively. Mitochondrial membrane potential was assessed using tetramethylrhodamine methyl ester (TMRM). Fibrotic markers (fibronectin, α-SMA, CTGF) were evaluated by immunofluorescent staining and Western blotting. RNA sequencing was performed to compare transcriptional profiles between TMSCs and TM cells. A cytokine array was used to compare TMSC-Scr and TM-Scr. A t-test or ANOVA followed by Tukey's multiple comparisons test was used for statistical analysis, with significance defined as P < 0.05.

Results

Compared with TM cells, TMSCs exhibited greater survival, better-preserved mitochondrial function, and lower levels of ROS, lipid peroxidation, and fibrotic marker expression after TGF-β2 treatment. N-acetylcysteine partially prevented TGF-β2 effects on TM cells. RNA sequencing and cytokine analyses identified significant enrichment of HGF in TMSCs and TMSC-Scr. TMSC-Scr and HGF markedly reduced oxidative and fibrotic responses to TGF-β2 in TM cells, whereas an HGFI abolished this protective effect.

Conclusions

Our findings confirm that TMSC-Scr and HGF are promising candidates for cell-free therapies in glaucoma. HGF confers intrinsic resilience in TMSCs and functions as a key, but partial, mediator of their protection of TM cells.

Subjects

MeSH terms (MEDLINE)

Trabecular MeshworkHepatocyte Growth FactorStem CellsGlaucomaParacrine CommunicationHumansCells, CulturedReactive Oxygen SpeciesCell SurvivalBlotting, WesternTransforming Growth Factor beta2Lipid PeroxidationMembrane Potential, Mitochondrial

Substances

Hepatocyte Growth FactorReactive Oxygen SpeciesTransforming Growth Factor beta2HGF protein, human

Authors and institutions

  • Department of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.

Funding

  • NEI NIH HHS

Cite

APA

Du, R., Yang, E., Ayyala, R., & Du, Y. (2026). Hepatocyte Growth Factor Confers Trabecular Meshwork Stem Cell Resilience and Paracrine Protection of Trabecular Meshwork Cells in Glaucoma. Investigative Ophthalmology & Visual Science, 67(4), 1. https://doi.org/10.1167/iovs.67.4.1

Vancouver

Du R, Yang E, Ayyala R, Du Y. Hepatocyte Growth Factor Confers Trabecular Meshwork Stem Cell Resilience and Paracrine Protection of Trabecular Meshwork Cells in Glaucoma. Investigative Ophthalmology & Visual Science. 2026;67(4):1. doi:10.1167/iovs.67.4.1

BibTeX
@article{Du2026,
  author = {Du, Rong and Yang, Enzhi and Ayyala, Ramesh and Du, Yiqin},
  title = {Hepatocyte Growth Factor Confers Trabecular Meshwork Stem Cell Resilience and Paracrine Protection of Trabecular Meshwork Cells in Glaucoma},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  volume = {67},
  number = {4},
  pages = {1},
  doi = {10.1167/iovs.67.4.1}
}
Start for free →